Development Drug Trials Life Science Trials 
Drug Discovery World
MARCH 7, 2023
For International Women’s Day, DDW’s Diana Spencer celebrates some of the women in leadership making an impact on the drug discovery and life sciences sector. The life sciences sector has traditionally outperformed others when it comes to attracting women to its workforce.
XTalks
AUGUST 3, 2022
Hear more about raising awareness about rare diseases like vitiligo and how it can help foster the development of new treatments. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Read the full articles here: Zonisamide Liquid Form Gets FDA Approved for Epilepsy Treatment.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
MAY 16, 2023
Clinical trials for pulmonary fibrosis are being conducted to evaluate the effectiveness of novel therapies and interventions, providing hope for improved outcomes in the future. Exposure to substances like asbestos, silica dust and certain chemicals has been linked to the development of pulmonary fibrosis.
XTalks
JULY 29, 2021
Just as clinical researchers in other therapeutic areas have renewed their commitment to improving participant diversity in clinical trials, so too have those working in Alzheimer’s research. What Factors Promote Alzheimer’s Clinical Trial Participation? Similarly, older Latino and Hispanic individuals are 1.5
XTalks
SEPTEMBER 11, 2020
Expanding minority Americans’ access to care and clinical trials isn’t just the right thing to do. Clinical Trials Don’t Reflect Demographics. Disease doesn’t discriminate, and researchers understand different populations react differently to drugs. Why, then, are clinical trials so stubbornly homogeneous?
Advarra
MARCH 21, 2023
Regulations for research involving devices, in vitro diagnostics (IVDs), and digital therapeutics differ from those governing pharmaceutical development. The greater the risk, the more likely a series of trials for market clearance or approval will be required. In other words, what are the risks and benefits of the product?
XTalks
FEBRUARY 25, 2022
There has been increasing awareness around the need for improving inclusion and diversity in clinical trials. They are also at a high risk of developing heart disease and stroke. times greater risk of developing kidney disease and are 2.3 times greater risk of developing kidney disease and are 2.3
Expert insights. Personalized for you.
98 
Let's personalize your content